Sertraline improves executive function in patients with vascular cognitive impairment

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 21, Issue 4, 2009, Pages 445-454

  Royall, Donald R ^a,b   Cordes, Jeffrey A ^b   Román, Gustavo ^b   Velez, Angela ^b   Edwards, Aaron ^b   Schillerstrom, Jason S ^b   Polk, Marsha J ^a,b  

^a Geriatric Research Education Clinical Center (GRECC)   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIARRHEA; DRUG DOSE TITRATION; DRUG WITHDRAWAL; GAIT DISORDER; GASTROINTESTINAL SYMPTOM; GERIATRIC DEPRESSION SCALE; HUMAN; INSOMNIA; MALE; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; PRIORITY JOURNAL; REMISSION; SLEEP DISORDER; TIC; TREMOR; VISUAL HALLUCINATION;

EID: 73549123891     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2009.21.4.445     Document Type: Article

References (40)

1. Royall DR: Frontal systems impairment in major depression. Semin Clin Neuropsychiatry 1999; 4:13-23
2. Massman PJ, Delis DC, Butters N, et al: The subcortical dysfunction hypothesis of memory deficits in depression: neuropsychological validation of a subgroup of patients. J Clin Exp Neuropsychol 1993; 14:687-706
3. Royall DR, Mahurin RK, Cornell J: Effect of depression on dementia presentation: qualitative assessment with the Qualitative Evaluation of Dementia (QED). J Geriatr Psychiatry Neurol 1995; 8:4-11
4. Royall DR, Polk MJ: Dementias that present with and without posterior cortical features: an important clinical distinction. J Am Geriatr Soc 1998; 46:98-105
5. Tuokko HA, Frerichs RJ, Kristjansson B: Cognitive impairment, no dementia: concepts and issues. Int Psychogeriatr 2001; 13:183-202
6. Winblad B, Palmer K, Kivipelto M, et al: Mild cognitive impairment: beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med 2004; 256:240-246
7. Román GC, Sachdev P, Royall DR, et al: Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 2004; 226:81-87
8. Royall DR, Lauterbach EC, Kaufer DI, et al: The cognitive correlates of functional status: a review from the committee on research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2007; 19:249-265
9. Royall DR: "Silent" stroke: an oxymoron meaning "dementia." Sem Cerebrovasc Dis Stroke 2005; 4:97-101
10. Royall DR: Mild cognitive impairment and functional status. J Am Geriatr Soc 2006; 54:163-165
11. Royall DR: The "Alzheimerization" of dementia research. J Am Geriatr Soc 2003; 51:277-278
12. Royall DR, Mahurin RK, Gray K: Bedside assessment of executive cognitive impairment: the Executive Interview (EXIT). J Am Geriatr Soc 1992; 40:1221-1226
13. Folstein M, Folstein S, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198 14. DeCoteau WE, Selk B, Stirling G, et al: The usefulness of the EXIT25 in a geriatric population with a well-preserved Mini-Mental Status Examination (MMSE). J Am Geriatr Soc 2004; 52(supp 1):S59-60
14. Royall DR, Cordes JA, Polk M: CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry 1998; 64:588-594
15. Cummings JL: Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50:873-880
16. Sheikh JI, Yesavage JA: Geriatric Depression Scale (GDSs): recent evidence and development of a shorter version, in Clinical Gerontology: A Guide to Assessment and Intervention. Edited by Brink TL. New York, Haworth Press, 1986, pp 165-173
17. Gerety MB, Williams JW Jr, Mulrow CD, et al: Performance of case-finding tools for depression in the nursing home: influence of clinical and functional characteristics and selection of optimal threshold scores. J Am Geriatr Soc 1994; 42:1103-1109
18. Royall DR, Mulroy A, Chiodo LK, et al: Clock drawing is sensitive to executive control: a comparison of six methods. J Gerontol B Psychol Sci Soc Sci 1999; 54:P328-333
19. Royall DR, Chiodo LK, Polk MJ: An empiric approach to level-of-care determinations: the importance of executive measures. J Gerontol A Biol Sci Med Sci 2005; 60:1059-1064
20. Royall DR, Chiodo LK, Mouton C, et al: Cognitive predictors of mortality in elderly retirees: results from the freedom house study. Am J Geriatr Psychiatry 2007; 15:243-251
21. Royall DR, Cabello M, Polk MJ: Executive dyscontrol: an important factor affecting the level of care received by elderly retirees. J Am Geriatr Soc 1998; 46:1519-1524
22. Royall DR, Palmer R, Chiodo LK, et al: Executive control mediates memory's association with change in functional status: the Freedom House Study. J Am Geriatr Soc 2005; 53: 11-17
23. Allen SC, Jain M, Ragab S, et al: Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects. Age Ageing 2003; 32:299-302
24. Dymek MP, Atchison P, Harrell L, et al: Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease. Neurology 2001; 56:17-24
25. Royall DR, Chiodo LK, Polk M: Executive dyscontrol in normal aging: normative data, factor structure, and clinical correlates. Curr Neurol Neurosci Rep 2003; 3:487-493
26. Aguilar M, Román G, Black S, et al: Efficacy and Safety of Donepezil in Vascular Dementia: Results From the Largest Double-Blind Trial in Vascular Dementia Patients [Abstract]. 10th International Conference on Alzheimer's Disease. Mardrid, Spain, July 19, 2006
27. Auchus AP, Brashear HR, Salloway S, et al: Results of a Trial of Galantamine in Subjects With Vascular Dementia Confirmed by Central MRI Reading [Abstract]. American Academy of Neurology Meeting, San Francisco, Calif, April 27, 2004
28. Chan SMS, Chiu FKH, Lam CWL: Correlational study of the Chinese version of the executive interview (C-exit25) to other cognitive measures in a psychogeriatric population in Hong Kong Chinese. Int J Geriatr Psychiatry 2006; 21:535-541
29. O'Shaughnessy JA, Vukelja SJ, Holmes FA, et al: Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clin Breast Cancer 2005; 5:439-446
30. Royall DR, Palmer R, Chiodo LK, et al: Normal rates of cognitive change in successful aging: the Freedom House Study. J Int Neuropsychological Soc 2005; 11:899-909
31. Hauser RA, Zesiewicz TA: Sertraline-induced exacerbation of tics in Tourette's syndrome. Mov Disord 1995; 10:682-684
32. Finkel SI, Richter EM, Clary CM: Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older. Int Psychogeriatr 1999; 11:85-99
33. Finkel SI, Richter EM, Clary CM, et al: Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression. Am J Geriatr Psychiatry 1999; 7:221-227
34. Riedel WJ, Eikmans K, Heldens A, et al: Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. J Clin Pharmacol 2005; 19: 12-20
35. Tatsumi M, Groshan K, Blakely RD, et al: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997; 340:249-258
36. Hyttel J: Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 1994; 9:19-26
37. Taylor D, Ho BT: Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. Res Commun Chem Pathol Pharmacol 1978; 21:67-75
38. Narushima K, Paradiso S, Moser DJ, et al: Effect of antidepressant therapy on executive function after stroke. Br J Psychiatry 2007; 190:260-265
39. Devanand DP, Pelton GH, Marston K, et al: Sertraline treatment of elderly patients with depression and cognitive impairment. Int J Geriatr Psychiatry 2003; 18:123-130
40. Newhouse PA, Krishnan KR, Doraiswamy PM, et al: A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry 2000; 61:559-568